Medical oncologsts discuss the case of a 70-year old woman with synchronous multiple primary lung cancer.
Mehmet Sitki Copur, MD, FACP
A 79-year-old white man presented with an ulcerated chest wall lesion developing from an existing mole.
A 39-year-old Hispanic male presented with complaints of mucous stools, loss of appetite, rectal bleeding and a 30-pound weight loss within the past several months.
Prostate cancer is the most common malignancy and second leading cause of cancer death among males in the United States.
Burnout is defined as an occupational-related syndrome characterized by physical and emotional exhaustion, cynicism/depersonalization, and low sense of professional accomplishment.
Highlights of breast cancer advances at the ESMO Congress.
The US Food and Drug Administration recently approved alpelisib plus fulvestrant for the treatment of metastatic or otherwise advanced breast cancer.
Immune checkpoint inhibitors have demonstrated impressive activity in patients with CRC and other solid tumors that are dMMR. Researchers explore the data.
Most recently, the FDA approved cabozantinib for the treatment of HCC, but this drug has a history.